<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: A universal hallmark of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cells is the change in their glycosylation phenotype </plain></SENT>
<SENT sid="1" pm="."><plain>One of the most frequent alterations in the <z:mpath ids='MPATH_458'>normal</z:mpath> glycosylation pattern observed during <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> is the enhancement of α(1,6)linked <z:chebi fb="0" ids="33984">fucose</z:chebi> residues of <z:chebi fb="0" ids="17089">glycoproteins</z:chebi>, due to the up-regulation of the α(1,6)fucosyltransferase activity </plain></SENT>
<SENT sid="2" pm="."><plain>Our previous results demonstrated the specific alteration of this enzyme activity and expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, suggesting its implication in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> development and progression </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: In the current work we combined a LCA-affinity chromatography with <z:chebi fb="26" ids="8984">SDS</z:chebi>-PAGE and mass spectrometry in order to identify α(1,6)fucosylated proteins differentially expressed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>This strategy allowed the identification of a group of α(1,6)fucosylated proteins candidates to be involved in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: The majority of the identified proteins take part in cell signaling and interaction processes as well as in modulation of the immunological response </plain></SENT>
<SENT sid="6" pm="."><plain>Likewise, we confirmed the increased expression of GRP94 in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> tissue and the significant down-regulation of the IgGFcBP expression in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:hpo ids='HP_0000001'>All</z:hpo> these results validate the importance of core-fucosylated proteins profile analysis to understand the mechanisms which promote <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> <z:hpo ids='HP_0003674'>onset</z:hpo> and progression and to discover new <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> markers or therapeutic targets </plain></SENT>
</text></document>